A. Y. Choo

发表

Anti-tumor activity mediated by protein and peptide transduction of HIV viral protein R (Vpr)

J. Kim, D. Weiner, K. Ugen, 2009, Cancer biology & therapy.

DNA vaccination in immunotherapy of cancer.

J. Kim, D. Weiner, D. Choo, 2005, Cancer treatment and research.

Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism

D. Weiner, K. Muthumani, K. Thieu, 2005, Cell Death and Differentiation.

ATM: Promoter of metabolic "cost" reduction and "savings" usage during hypoxia through mTORC1 regulation.

Sang Gyun Kim, J. Blenis, A. Y. Choo, 2010, Molecular cell.

HIV-1 Vpr: enhancing sensitivity of tumors to apoptosis.

D. Weiner, K. Ugen, K. Muthumani, 2004, Current drug delivery.

HIV-Mediated Phosphatidylinositol 3-Kinase/Serine–Threonine Kinase Activation in APCs Leads to Programmed Death-1 Ligand Upregulation and Suppression of HIV-Specific CD8 T Cells

D. Weiner, P. Fagone, P. Tebas, 2011, The Journal of Immunology.

HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.

D. Weiner, P. Buckley, K. Muthumani, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Human Immunodeficiency Virus Type 1 Nef Induces Programmed Death 1 Expression through a p38 Mitogen-Activated Protein Kinase-Dependent Mechanism

D. Weiner, G. Silvestri, P. Tebas, 2008, Journal of Virology.

Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice.

D. Weiner, M. Kutzler, K. Ugen, 2006, Vaccine.

Electric Fields for Vaccine Delivery: How In Vivo Electroporation Could Fulll the Promise of DNA Vaccines

N. Sardesai, J. Kim, A. Y. Choo, 2011 .

Induction of Potent Th 1-Type Immune Responses from a Novel DNA Vaccine for West Nile Virus New York Isolate ( WNV-NY 1999 )

M. Ramanathan, J. Kim, D. Weiner, 2001 .

Electroporation of cytokines for cancer gene therapy

K. Muthumani, D. Shedlock, A. Y. Choo, 2009, Cancer biology & therapy.

This information is current as Independent of CD4 T Cell Help Longevity of CD8 T Cells That Are Partially Plasmid Results in Enhanced Function and Coimmunization with an Optimized IL-15

T. Waldmann, M. Ramanathan, J. Kim, 2013 .

Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex.

Sang Gyun Kim, J. Blenis, L. Cantley, 2013, Molecular cell.

Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

Sang Gyun Kim, J. Blenis, L. Cantley, 2010, Molecular cell.

The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

Gregory Stephanopoulos, George Poulogiannis, Sarah-Maria Fendt, 2013, Cell.

HIV-1 viral genes and mitochondrial apoptosis

D. Weiner, K. Muthumani, D. Shedlock, 2008, Apoptosis.

TORgeting oncogene addiction for cancer therapy.

J. Blenis, A. Y. Choo, 2006, Cancer cell.

HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.

D. Weiner, K. Muthumani, K. Thieu, 2004, International immunology.

Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor

D. Weiner, J. Siekierka, K. Muthumani, 2004, AIDS.

Mechanism of HIV-1 viral protein R-induced apoptosis.

Karuppiah Muthumani, D. Weiner, K. Muthumani, 2003, Biochemical and biophysical research communications.

Induction of Inflammation by West Nile virus Capsid through the Caspase-9 Apoptotic Pathway

M. Ramanathan, J. Kim, D. Weiner, 2002, Emerging infectious diseases.

HIV-1 Vpr and anti-inflammatory activity.

D. Weiner, Dominick J. Laddy, K. Muthumani, 2004, DNA and cell biology.

Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance, and cancer therapy

J. Blenis, A. Y. Choo, 2009, Cell cycle.

Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation

Sang Gyun Kim, J. Blenis, Philippe P Roux, 2008, Proceedings of the National Academy of Sciences.

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.

D. Weiner, S. Calarota, J. Boyer, 2003, Virology.

The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1

D. Weiner, W. Zong, C. Thompson, 2006, Nature Cell Biology.

Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help3

T. Waldmann, M. Ramanathan, J. Kim, 2005, The Journal of Immunology.

Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).

M. Ramanathan, J. Kim, D. Weiner, 2001, The Journal of infectious diseases.

HIV-1 Vpr: regulator of viral survival.

D. Weiner, P. Fagone, K. Muthumani, 2009, Current HIV research.

HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation.

Crafford A. Harris, D. Green, D. Weiner, 2005, Blood.

Mind the GAP: Wnt Steps onto the mTORC1 Train

J. Blenis, Philippe P Roux, A. Y. Choo, 2006, Cell.

Suppression of HIV-Specific CD8 T Cells Death-1 Ligand Upregulation and Activation in APCs Leads to Programmed Threonine Kinase - 3-Kinase/Serine HIV-Mediated Phosphatidylinositol

D. Weiner, P. Fagone, P. Tebas, 2011 .

MAPK activation HIV-1 Nef-induced FasL induction and bystander killing requires p38

D. Green, J. Siekierka, A. Y. Choo, 2013 .

The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4

Douglas J. Chapski, G. Stephanopoulos, J. Blenis, 2021, Cell.

The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4

Douglas J. Chapski, G. Stephanopoulos, J. Blenis, 2021, Cell.

The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

Douglas J. Chapski, G. Stephanopoulos, J. Blenis, 2013, Cell.